A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities
Clinical trial NCT02915224 · COMPLETED
Trial details
- NCT number
- NCT02915224
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-11-23
- Primary completion
- 2021-06-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.